Macular Degeneration Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- Adults aged 18 or older
- People who have been diagnosed with an idiopathic epiretinal membrane (a type of scar tissue that forms on the surface of the retina) confirmed by eye examination and a special eye scan called OCT imaging
- People whose eye has clear enough internal structures to allow detailed imaging of the back of the eye
- People who still have their natural lens in the eye being studied (the eye has not had cataract surgery)
- People who are able and willing to sign a written consent form agreeing to take part
Who may not be able to join:
- People who have had cataract surgery in the eye being studied, or who have a severe cataract that would need to be treated at the same time as the main surgery
- People who have other retinal conditions in the affected eye, such as diabetic retinopathy, a detached retina, or a blocked retinal vein
- People who have health conditions that would make surgery or follow-up appointments unsafe
- People who have a history of using steroid (corticosteroid) medications in or around the eye, including injections into or around the eye, or long-term use of steroid eye drops
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Weihong Yu, MD, Peking Union Medical College Hospital
Phone: +8613671214306
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Cataract progression assessed by LOCS III and DLI
Can't join this trial?
Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.